Literature DB >> 16839750

Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins.

Aija Kyttälä1, Ulla Lahtinen, Thomas Braulke, Sandra L Hofmann.   

Abstract

Neuronal ceroid lipofucinoses (NCLs) are a group of severe neurodegenerative disorders characterized by accumulation of autofluorescent ceroid lipopigment in patients' cells. The different forms of NCL share many similar pathological features but result from mutations in different genes. The genes affected in NCLs encode both soluble and transmembrane proteins and are localized to ER or to the endosomes/lysosomes. Due to selective vulnerability of the central nervous system in the NCL disorders, the corresponding proteins are proposed to have important, tissue specific roles in the brain. The pathological similarities of the different NCLs have led not only to the grouping of these disorders but also to suggestion that the NCL proteins function in the same biological pathway. Despite extensive research, including the development of several model organisms for NCLs and establishment of high-throughput techniques, the precise biological function of many of the NCL proteins has remained elusive. The aim of this review is to summarize the current knowledge of the functions, or proposed functions, of the different NCL proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16839750     DOI: 10.1016/j.bbadis.2006.05.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  37 in total

Review 1.  [Genetics of neuronal ceroidlipofuscinoses. Aspects of genetic counseling].

Authors:  M N Preising; B Lorenz
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

2.  TRAM1 is involved in disposal of ER membrane degradation substrates.

Authors:  Caroline L Ng; Kristina Oresic; Domenico Tortorella
Journal:  Exp Cell Res       Date:  2010-04-27       Impact factor: 3.905

3.  Oligomerization of Cysteine String Protein alpha mutants causing adult neuronal ceroid lipofuscinosis.

Authors:  Yong-Quan Zhang; Sreeganga S Chandra
Journal:  Biochim Biophys Acta       Date:  2014-07-23

4.  Analysis of potential biomarkers and modifier genes affecting the clinical course of CLN3 disease.

Authors:  Anne-Hélène Lebrun; Parisa Moll-Khosrawi; Sandra Pohl; Georgia Makrypidi; Stephan Storch; Dirk Kilian; Thomas Streichert; Benjamin Otto; Sara E Mole; Kurt Ullrich; Susan Cotman; Alfried Kohlschütter; Thomas Braulke; Angela Schulz
Journal:  Mol Med       Date:  2011-08-18       Impact factor: 6.354

Review 5.  Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.

Authors:  R Kohan; I A Cismondi; A M Oller-Ramirez; N Guelbert; Tapia V Anzolini; G Alonso; S E Mole; Dodelson R de Kremer; Noher I de Halac
Journal:  Curr Pharm Biotechnol       Date:  2011-06       Impact factor: 2.837

6.  Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients.

Authors:  Clarissa Valdez; Yvette C Wong; Michael Schwake; Guojun Bu; Zbigniew K Wszolek; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

7.  Cln6 mutants associated with neuronal ceroid lipofuscinosis are degraded in a proteasome-dependent manner.

Authors:  Kristina Oresic; Britta Mueller; Domenico Tortorella
Journal:  Biosci Rep       Date:  2009-06       Impact factor: 3.840

8.  Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).

Authors:  Megan E Bosch; Amy Aldrich; Rachel Fallet; Jessica Odvody; Maria Burkovetskaya; Kaitlyn Schuberth; Julie A Fitzgerald; Kevin D Foust; Tammy Kielian
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

Review 9.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

10.  Novel interactions of CLN5 support molecular networking between Neuronal Ceroid Lipofuscinosis proteins.

Authors:  Annina Lyly; Carina von Schantz; Claudia Heine; Mia-Lisa Schmiedt; Tessa Sipilä; Anu Jalanko; Aija Kyttälä
Journal:  BMC Cell Biol       Date:  2009-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.